Adam Maeder
Stock Analyst at Piper Sandler
(4.30)
# 476
Out of 4,829 analysts
85
Total ratings
55.81%
Success rate
14.42%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | $25 → $14 | $9.88 | +41.70% | 3 | May 6, 2025 | |
| RMD ResMed | Maintains: Neutral | $260 → $248 | $247.57 | +0.17% | 3 | Apr 24, 2025 | |
| EW Edwards Lifesciences | Upgrades: Overweight | $73 → $80 | $74.24 | +7.76% | 14 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $670 → $575 | $558.36 | +2.98% | 19 | Apr 23, 2025 | |
| ABT Abbott Laboratories | Reiterates: Overweight | $133 → $145 | $132.53 | +9.41% | 3 | Apr 17, 2025 | |
| RXST RxSight | Initiates: Neutral | $18 | $13.88 | +29.68% | 1 | Apr 15, 2025 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $11 → $8.5 | $8.70 | -2.30% | 7 | Mar 18, 2025 | |
| INSP Inspire Medical Systems | Maintains: Overweight | $260 → $233 | $156.47 | +48.91% | 14 | Feb 10, 2025 | |
| NSPR InspireMD | Reiterates: Overweight | $4.5 | $2.53 | +77.87% | 3 | Sep 17, 2024 | |
| M Macy's | Maintains: Hold | $20 → $21 | $12.33 | +70.32% | 2 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 → $8 | $4.31 | +85.61% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $5.93 | +237.27% | 8 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.12 | +135.85% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $10 → $18 | $2.19 | +721.92% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $45.25 | +118.78% | 3 | May 5, 2022 |
Tactile Systems Technology
May 6, 2025
Downgrades: Neutral
Price Target: $25 → $14
Current: $9.88
Upside: +41.70%
ResMed
Apr 24, 2025
Maintains: Neutral
Price Target: $260 → $248
Current: $247.57
Upside: +0.17%
Edwards Lifesciences
Apr 24, 2025
Upgrades: Overweight
Price Target: $73 → $80
Current: $74.24
Upside: +7.76%
Intuitive Surgical
Apr 23, 2025
Maintains: Overweight
Price Target: $670 → $575
Current: $558.36
Upside: +2.98%
Abbott Laboratories
Apr 17, 2025
Reiterates: Overweight
Price Target: $133 → $145
Current: $132.53
Upside: +9.41%
RxSight
Apr 15, 2025
Initiates: Neutral
Price Target: $18
Current: $13.88
Upside: +29.68%
Vicarious Surgical
Mar 18, 2025
Maintains: Neutral
Price Target: $11 → $8.5
Current: $8.70
Upside: -2.30%
Inspire Medical Systems
Feb 10, 2025
Maintains: Overweight
Price Target: $260 → $233
Current: $156.47
Upside: +48.91%
InspireMD
Sep 17, 2024
Reiterates: Overweight
Price Target: $4.5
Current: $2.53
Upside: +77.87%
Macy's
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $12.33
Upside: +70.32%
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $4.31
Upside: +85.61%
Mar 6, 2024
Maintains: Overweight
Price Target: $15 → $20
Current: $5.93
Upside: +237.27%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $2.12
Upside: +135.85%
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $2.19
Upside: +721.92%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $45.25
Upside: +118.78%